[
  {
    "ts": "2026-01-29T01:50:00+00:00",
    "headline": "Missed Out on Eli Lilly? This GLP-1 Stock Could Be a Bargain Buy.",
    "summary": "Amgen may not have an approved GLP-1 treatment just yet, but that could change in the future.",
    "url": "https://www.fool.com/investing/2026/01/28/miss-out-eli-lilly-glp-1-stock-bargain-buy-amgen/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "72261e37-79a4-3156-adff-231dd1be9418",
      "content": {
        "id": "72261e37-79a4-3156-adff-231dd1be9418",
        "contentType": "STORY",
        "title": "Missed Out on Eli Lilly? This GLP-1 Stock Could Be a Bargain Buy.",
        "description": "",
        "summary": "Amgen may not have an approved GLP-1 treatment just yet, but that could change in the future.",
        "pubDate": "2026-01-29T01:50:00Z",
        "displayTime": "2026-01-29T01:50:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/b14fe782cab24ef947fce46c4572e9b5",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "A group of business people talking outside.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wnQGWxAjUP_RumiFWWHD4A--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/b14fe782cab24ef947fce46c4572e9b5.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/j.iK9zNtYOI_ImHtY8p5HA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/b14fe782cab24ef947fce46c4572e9b5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/01/28/miss-out-eli-lilly-glp-1-stock-bargain-buy-amgen/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/missed-eli-lilly-glp-1-015000794.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-29T14:15:04+00:00",
    "headline": "Countdown to Amgen (AMGN) Q4 Earnings: Wall Street Forecasts for Key Metrics",
    "summary": "Get a deeper insight into the potential performance of Amgen (AMGN) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.",
    "url": "https://finance.yahoo.com/news/countdown-amgen-amgn-q4-earnings-141504375.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "ba8c82b4-01d7-350e-a907-2379e46f0f4d",
      "content": {
        "id": "ba8c82b4-01d7-350e-a907-2379e46f0f4d",
        "contentType": "STORY",
        "title": "Countdown to Amgen (AMGN) Q4 Earnings: Wall Street Forecasts for Key Metrics",
        "description": "",
        "summary": "Get a deeper insight into the potential performance of Amgen (AMGN) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.",
        "pubDate": "2026-01-29T14:15:04Z",
        "displayTime": "2026-01-29T14:15:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/b9775f315e7b6c4ada6e36d0048a929a",
          "originalWidth": 900,
          "originalHeight": 728,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qda7CGFBlQ8XGALeSrKgqg--~B/aD03Mjg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b9775f315e7b6c4ada6e36d0048a929a.cf.webp",
              "width": 900,
              "height": 728,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4xjRGdTikgXo5SMeFUiNTA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b9775f315e7b6c4ada6e36d0048a929a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/countdown-amgen-amgn-q4-earnings-141504375.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/countdown-amgen-amgn-q4-earnings-141504375.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-29T17:24:16+00:00",
    "headline": "UBS Raises Amgen (AMGN) Target as Pharma and Biotech Setup Improves",
    "summary": "Amgen Inc. (NASDAQ:AMGN) is included among the 12 Best Dow Jones Dividend Stocks to Buy According to Hedge Funds. On January 26, UBS lifted its price target on Amgen Inc. (NASDAQ:AMGN) to $390 from $380 and kept a Buy rating on the stock. The call reflects a more constructive view on the broader US pharma […]",
    "url": "https://finance.yahoo.com/news/ubs-raises-amgen-amgn-target-172416337.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "6dc04329-cc49-3b0f-9e37-af9b91dc958a",
      "content": {
        "id": "6dc04329-cc49-3b0f-9e37-af9b91dc958a",
        "contentType": "STORY",
        "title": "UBS Raises Amgen (AMGN) Target as Pharma and Biotech Setup Improves",
        "description": "",
        "summary": "Amgen Inc. (NASDAQ:AMGN) is included among the 12 Best Dow Jones Dividend Stocks to Buy According to Hedge Funds. On January 26, UBS lifted its price target on Amgen Inc. (NASDAQ:AMGN) to $390 from $380 and kept a Buy rating on the stock. The call reflects a more constructive view on the broader US pharma […]",
        "pubDate": "2026-01-29T17:24:16Z",
        "displayTime": "2026-01-29T17:24:16Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/51e557354b24b248245adac46ac0da45",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "UBS Raises Amgen (AMGN) Target as Pharma and Biotech Setup Improves",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fl9k_iPg0JyfVI.qZJRd8A--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/51e557354b24b248245adac46ac0da45.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RgojEqpZ8ITlaPGpQimL8Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/51e557354b24b248245adac46ac0da45.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ubs-raises-amgen-amgn-target-172416337.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ubs-raises-amgen-amgn-target-172416337.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "UBS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]